Hepatic Hemangioendothelioma: An update

Table 1 Summaries of medical management studies for hepatic hemangioepithelioma

Study	Year	Country	Patients	Medical management	Dose	Outcome	Duration of follow up
Salech et al[78]	2010	Chile	1	Thalidomide	300 mg daily	Partial response	109 mo
Raphael et al[79]	2010	United Kingdom	1	Thalidomide	400 mg daily	Stable disease	84 mo
Kassam and Mandel[80]	2008	Canada	1	Thalidomide	400 mg twice daily	Progressive disease	Not available
Bolke et al[81]	2006	Germany	1	Thalidomide	Unknown	Progressive disease/death	Not available
Mascarenhas et al[49]	2005	United States	1	Thalidomide	Unknown	Partial response	Not available
Soape et al[60]	2015	United States	1	Thalidomide	200 mg nightly	Progressive disease	12 mo